Literature DB >> 34997852

Imaging correlates of depression in progressive supranuclear palsy.

Daniele Urso1,2, Benedetta Tafuri1,3, Roberto De Blasi4, Salvatore Nigro1,5, Giancarlo Logroscino6,7.   

Abstract

Depression is highly common in Progressive Supranuclear Palsy (PSP) and is a meaningful determinant of quality of life. However, neurobiological and neuroimaging correlates of this neuropsychiatric disturbance in PSP patients are still unknown. In this study, we aimed to investigate the topographical distribution of morphometric changes associated with depression in PSP patients using cortical thickness. Forty patients with PSP were evaluated at baseline with clinical rating scales and MRI scans. Based on the response to the 15-item Geriatric Depression Scale we identified 21 PSP patients with depression (GDS-15 score ≥ 5) and 19 PSP patients without depression (GDS-15 score < 5). In vertex-wise analysis, comparison of cortical thickness between PSP patients with and without depression was performed using a general linear model. PSP patients with depressions showed reduced cortical thickness in temporo-parieto-occipital areas, more pronounced in the right hemisphere. These findings propose neurobiological conceptualizations of depression in PSP as being associated with a multiregional pattern of morphometric grey matter reduction.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cortical thickness; Depression; MRI; PSP

Mesh:

Year:  2022        PMID: 34997852     DOI: 10.1007/s00415-021-10939-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  46 in total

1.  Psychiatric disturbances in patients with progressive supranuclear palsy: a case-control study.

Authors:  Maria Carmela Bloise; Isabella Berardelli; Valentina Roselli; Massimo Pasquini; Paola Stirpe; Carlo Colosimo; Alfredo Berardelli; Giovanni Fabbrini
Journal:  Parkinsonism Relat Disord       Date:  2014-06-10       Impact factor: 4.891

Review 2.  Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.

Authors:  Adam L Boxer; Jin-Tai Yu; Lawrence I Golbe; Irene Litvan; Anthony E Lang; Günter U Höglinger
Journal:  Lancet Neurol       Date:  2017-06-13       Impact factor: 44.182

3.  Health-related quality of life in multiple system atrophy and progressive supranuclear palsy.

Authors:  Yaroslav Winter; Annika E Spottke; Maria Stamelou; Nicole Cabanel; Karla Eggert; Günter U Höglinger; Friederike Sixel-Doering; Birgit Herting; Thomas Klockgether; Heinz Reichmann; Wolfgang H Oertel; Richard Dodel
Journal:  Neurodegener Dis       Date:  2011-05-12       Impact factor: 2.977

4.  Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.

Authors:  D Aarsland; I Litvan; J P Larsen
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

5.  Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy.

Authors:  T Esmonde; E Giles; M Gibson; J R Hodges
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

6.  Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

Authors:  Gabriella Santangelo; Sofia Cuoco; Maria Teresa Pellecchia; Roberto Erro; Paolo Barone; Marina Picillo
Journal:  J Neurol       Date:  2018-09-03       Impact factor: 4.849

Review 7.  Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

Authors:  J J Hauw; S E Daniel; D Dickson; D S Horoupian; K Jellinger; P L Lantos; A McKee; M Tabaton; I Litvan
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

8.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  K A Jellinger; C Bancher; J J Hauw; M Verny
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

9.  A Systematic Review of Apathy and Depression in Progressive Supranuclear Palsy.

Authors:  Joshua Flavell; Peter J Nestor
Journal:  J Geriatr Psychiatry Neurol       Date:  2021-02-11       Impact factor: 2.680

10.  Non motor symptoms in progressive supranuclear palsy: prevalence and severity.

Authors:  Fabiana Giada Radicati; Pablo Martinez Martin; Chiara Fossati; Kallol Ray Chaudhuri; Margherita Torti; Carmen Rodriguez Blazquez; Laura Vacca; Fabrizio Stocchi
Journal:  NPJ Parkinsons Dis       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.